Browse 26479 Federal Health Grants below, sorted by the deadline to apply.
The United States Government agency or department offering the grant is also listed.
Select a specific Health grant to read the full description of the opportunity.
The full description contains the grant type, total award amount, eligible applicants, important dates, and official contact details.
If you wish to search for a specific keyword or view grants sorted by governmental agency, use the links on the menu bar.
| Close Date | Grant Title | Agency |
| December 6th, 2024 |
HEAL Initiative: Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
| October 1st, 2024 |
NIA Renewal and Competing Revision Cooperative Agreements in Aging Research (U01 Clinical Trial Optional) |
National Institutes of Health |
| May 20th, 2022 |
Host Immunity and Novel Immunization Strategies for Clostridioides difficile Infection (CDI) (U19 Clinical Trial Not Allowed) |
National Institutes of Health |
| March 14th, 2022 |
Stroke Preclinical Assessment Network (SPAN) to Support Translational Studies for Acute Cerebroprotection- Interventions from Small Businesses (U44 Clinical Trial Not Allowed) |
National Institutes of Health |
| March 14th, 2022 |
Limited Competition: Stroke Preclinical Assessment Network (SPAN) to Support Translational Studies for Acute Cerebroprotection - Coordinating Center (U24 Clinical Trial Not Allowed) |
National Institutes of Health |
| March 14th, 2022 |
Pre-Solicitation Notice - Guinea Local Health System Strengthening |
Guinea USAID Conakry |
| March 28th, 2024 |
Physician Scientist Transition to Independence in Blood Science Research (R00 - Clinical Trial Optional) |
National Institutes of Health |
| April 4th, 2022 |
Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional) |
National Institutes of Health |
| May 16th, 2022 |
Coordinating Center for the Claude D. Pepper Older Americans Independence Centers (OAICs) (U24 Clinical Trial Optional) |
National Institutes of Health |
| January 22nd, 2022 |
Emergency Awards: HEAL Initiative: Translational Science Career Enhancement Awards for Early and Mid-career Investigators (K18 Clinical Trials Not Allowed) |
National Institutes of Health |
| March 14th, 2022 |
Stroke Preclinical Assessment Network (SPAN) to Support Translational Studies for Acute Cerebroprotection - Testing Laboratories (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
| March 14th, 2022 |
Stroke Preclinical Assessment Network (SPAN) to Support Translational Studies For Acute Cerebroprotection- Interventions (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
| April 4th, 2022 |
Technologies for Improving Minority Health and Eliminating Health Disparities (R41/R42- Clinical Trial Optional) |
National Institutes of Health |
| June 15th, 2022 |
Pharmacokinetic and Pharmacodynamic (PK/PD) Studies of mTOR Inhibitors on Aging-Related Indications (U01 Clinical Trial Required) |
National Institutes of Health |
| March 15th, 2022 |
Limited Competition: Development and Renovation of Housing, Breeding, and Research Spaces for Existing NIH-supported NHP Colonies (C06 Clinical Trial Not Allowed) |
National Institutes of Health |
| March 31st, 2022 |
Elucidating the heterogeneity of impaired awareness of hypoglycemia in Type 1 Diabetes (T1D) Clinical Centers (U01 Clinical Trial Required) |
National Institutes of Health |
| March 30th, 2022 |
U.S. and Low- and Middle-Income Country (LMIC) HIV-Associated Malignancy Research Centers (U54 Clinical Trial Optional) |
National Institutes of Health |
| September 22nd, 2022 |
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional) |
National Institutes of Health |
| May 10th, 2022 |
Advancing communication strategies to support future HIV vaccine use (R21 Clinical Trial Optional) |
National Institutes of Health |
| March 31st, 2022 |
Teaching Health Center Graduate Medical Education (THCGME) Program |
Health Resources and Services Administration |
|
| March 10th, 2022 |
HEAL Initiative: HEAL Data2Action (HD2A) Data Infrastructure Support Center (U24 Clinical Trial Optional) |
National Institutes of Health |
| March 25th, 2022 |
HEAL Initiative: HEAL Data2Action Research Adoption Support Center (U2C Clinical Trial Optional) |
National Institutes of Health |
| November 4th, 2022 |
Maintaining and Enriching Environmental Epidemiology Cohorts to Support Scientific and Workforce Diversity (U24 Clinical Trial Not Allowed) |
National Institutes of Health |
| March 25th, 2022 |
Biomedical Research Facilities (C06 Clinical Trial Not Allowed) |
National Institutes of Health |
| March 31st, 2022 |
Elucidating the heterogeneity of impaired awareness of hypoglycemia in Type 1 Diabetes (T1D) - Biostatistics Research Center (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
| September 22nd, 2022 |
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U2C Clinical Trial Optional) |
National Institutes of Health |
| September 22nd, 2022 |
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trial Optional) |
National Institutes of Health |
| September 22nd, 2022 |
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trial Optional) |
National Institutes of Health |
| September 22nd, 2022 |
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trials Optional) |
National Institutes of Health |
| September 22nd, 2022 |
Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional) |
National Institutes of Health |
| September 22nd, 2022 |
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional) |
National Institutes of Health |
| May 10th, 2022 |
Advancing communication strategies to support future HIV vaccine use (R01 Clinical Trial Optional) |
National Institutes of Health |
| March 10th, 2022 |
HEAL Initiative: HEAL Data2Action Innovation Projects (R61/R33 Clinical Trial Optional) |
National Institutes of Health |
| March 10th, 2022 |
HEAL Initiative: HEAL Data2Action Modeling and Economic Resource Center (U24 Clinical Trial Optional) |
National Institutes of Health |
| March 10th, 2022 |
HEAL Initiative: Research Networks for the Study of Recovery Support Services for Persons Treated with Medications for Opioid Use Disorder (R24 Clinical Trial Optional) |
National Institutes of Health |
| March 10th, 2022 |
HEAL Initiative: Harm Reduction Policies, Practices, and Modes of Delivery for Persons with Substance Use Disorders (R01 Clinical Trial Optional) |
National Institutes of Health |
| March 10th, 2022 |
HEAL Initiative: Harm Reduction Policies, Practices, and Modes of Delivery for Persons with Substance Use Disorders: Coordination Center (R24 Clinical Trial Optional) |
National Institutes of Health |
| March 10th, 2022 |
HEAL Initiative: Planning Grants for Efficacy or Effectiveness Trials of Recovery Support Services for Individuals Treated with Medications for Opioid Use Disorder (R34 Clinical Trial Optional) |
National Institutes of Health |
| June 14th, 2022 |
Lipids in Brain Aging and Alzheimer's Disease (AD) and its Related Dementias (ADRD) (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
| March 10th, 2022 |
HEAL Initiative: Pilot and Feasibility Trials to Improve Prevention and Treatment Service Delivery for Polysubstance Use (R34 Clinical Trial Optional) |
National Institutes of Health |
